Form of paroxetine hydrochloride anhydrate
US5900423A · kind A · utility
17Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 1997 |
| Grant date | May 4, 1999 |
| Priority date | — |
| Expiry date | Sep 2, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G71/02
- WIPO fieldMacromolecular chemistry, polymers
- WIPO sectorChemistry
Abstract
"Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.